Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Neuropsychological and neuroimaging markers in early versus late-onset Alzheimer's disease.

Kaiser NC, Melrose RJ, Liu C, Sultzer DL, Jimenez E, Su M, Monserratt L, Mendez MF.

Am J Alzheimers Dis Other Demen. 2012 Nov;27(7):520-9. doi: 10.1177/1533317512459798. Epub 2012 Sep 17.

2.

Early-onset Alzheimer's disease: nonamnestic subtypes and type 2 AD.

Mendez MF.

Arch Med Res. 2012 Nov;43(8):677-85. doi: 10.1016/j.arcmed.2012.11.009. Epub 2012 Nov 21. Review.

3.

Three-year follow-up of a patient with early-onset Alzheimer's disease with presenilin-2 N141I mutation - case report and review of the literature.

Nikisch G, Hertel A, Kiessling B, Wagner T, Krasz D, Hofmann E, Wiedemann G.

Eur J Med Res. 2008 Dec 3;13(12):579-84. Review.

PMID:
19073399
4.

The concept of FDG-PET endophenotype in Alzheimer's disease.

During EH, Osorio RS, Elahi FM, Mosconi L, de Leon MJ.

Neurol Sci. 2011 Aug;32(4):559-69. doi: 10.1007/s10072-011-0633-1. Epub 2011 Jun 1. Review.

5.

[Brain profile of hypometabolism in early Alzheimer's disease: relationships with cognitive deficits and atrophy].

Ch├ętelat G, Desgranges B, Eustache F.

Rev Neurol (Paris). 2006 Oct;162(10):945-51. Review. French.

PMID:
17028562
6.

Early-Onset Alzheimer Disease.

Mendez MF.

Neurol Clin. 2017 May;35(2):263-281. doi: 10.1016/j.ncl.2017.01.005. Review.

PMID:
28410659
7.

Alzheimer's Disease: From Genetic Variants to the Distinct Pathological Mechanisms.

Sun Q, Xie N, Tang B, Li R, Shen Y.

Front Mol Neurosci. 2017 Oct 6;10:319. doi: 10.3389/fnmol.2017.00319. eCollection 2017. Review.

Supplemental Content

Support Center